RTL
ATXS

Red Tortoise LLC’s Astria Therapeutics ATXS Stock Holding History

Red Tortoise LLC’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-298
Closed -$1.59K – 604
2025
Q1 		$1.59K Hold
298
– – ﹤0.01% 538
2024
Q4 		$2.66K Hold
298
– – ﹤0.01% 475
2024
Q3 		$3.28K Hold
298
– – ﹤0.01% 432
2024
Q2 		$2.71K Hold
298
– – ﹤0.01% 456
2024
Q1 		$4.19K Hold
298
– – ﹤0.01% 373
2023
Q4 		$2.29K Buy
+298
New +$1.65K ﹤0.01% 448

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Red Tortoise LLC's ATXS Position: Q2 2025 in Review

Red Tortoise LLC sold out of Astria Therapeutics (ATXS) in Q2 2025, closing a stake of 298 shares — an estimated $1.59K sold.

Red Tortoise LLC first reported a position in ATXS in Q4 2023 and held it in 6 quarters. The position peaked at $4.19K in Q1 2024. 105 funds tracked by Wall St. Rank hold ATXS as of Q2 2025.

  • Red Tortoise LLC reported no remaining Astria Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Red Tortoise LLC sold 298 Astria Therapeutics shares in Q2 2025, an estimated $1.59K.
  • Red Tortoise LLC first reported a position in Astria Therapeutics in Q4 2023 and held it in 6 quarters.
  • Red Tortoise LLC's Astria Therapeutics position peaked at $4.19K in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2025.

Based on Red Tortoise LLC's 13F filing for Q2 2025, filed 22 Jul 2025.